Page last updated: 2024-12-05

poldine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Poldine is a synthetic anticholinergic drug that acts as a muscarinic antagonist. It was first synthesized in the 1950s and was initially studied for its potential use in treating various conditions, including Parkinson's disease, peptic ulcer disease, and motion sickness. However, its use has declined due to the development of more effective and safer alternatives. Poldine is a quaternary ammonium compound and is closely related to other anticholinergics such as atropine and scopolamine. It works by blocking the action of acetylcholine at muscarinic receptors, which are found in the nervous system, heart, and smooth muscles. This blocking action leads to a range of effects, including decreased gastric acid secretion, reduced intestinal motility, and dilation of pupils. Despite its limited clinical use, poldine is still studied in research settings to explore its potential applications in other areas, such as in the treatment of neurodegenerative diseases and in the development of new drugs for other conditions.'

poldine: major descriptor (66-86); on-line search BENZILATES (66-86); INDEX MEDICUS search POLDINE (66-86); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11018
CHEMBL ID2110948
CHEBI ID135443
SCHEMBL ID1641786
MeSH IDM0263377

Synonyms (13)

Synonym
poldine
CHEBI:135443
(1,1-dimethylpyrrolidin-1-ium-2-yl)methyl 2-hydroxy-2,2-diphenylacetate
8r92106w2f ,
pyrrolidinium, 2-(((hydroxydiphenylacetyl)oxy)methyl)-1,1-dimethyl-
unii-8r92106w2f
596-50-9
poldine [who-dd]
SCHEMBL1641786
CHEMBL2110948
DB13507
Q7209234
DTXSID60862161
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
diarylmethaneAny compound containing two aryl groups connected by a single C atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (95.45)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.78 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index78.16 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (31.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.35%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]